These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31339797)

  • 1. Guanfacine extended-release for cannabis use disorder: a pilot feasibility trial.
    Dakwar E; Mahony A; Choi CJ; Pavlicova M; Brooks D; Mariani JP; Levin FR
    Am J Drug Alcohol Abuse; 2020; 46(1):44-48. PubMed ID: 31339797
    [No Abstract]   [Full Text] [Related]  

  • 2. Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers.
    Haney M; Cooper ZD; Bedi G; Herrmann E; Comer SD; Reed SC; Foltin RW; Levin FR
    Addict Biol; 2019 Jul; 24(4):707-716. PubMed ID: 29659126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study.
    Mathai DS; Holst M; Rodgman C; Haile CN; Keller J; Hussain MZ; Kosten TR; Newton TF; Verrico CD
    J Neuropsychiatry Clin Neurosci; 2018; 30(1):66-76. PubMed ID: 28641496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Guanfacine for Cannabis Use Disorder and Related Symptomology.
    Holst M; Mathai DS; Patel MM; Rodgman C; Keller J; Hussain MZ; De La Garza R; Kosten TR; Verrico CD
    Am J Addict; 2019 Nov; 28(6):455-464. PubMed ID: 31483544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label pilot study of injectable naltrexone for cannabis dependence.
    Notzon DP; Kelly MA; Choi CJ; Pavlicova M; Mahony AL; Brooks DJ; Mariani JJ; Levin FR
    Am J Drug Alcohol Abuse; 2018; 44(6):619-627. PubMed ID: 29420073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder.
    Scahill L; McCracken JT; King BH; Rockhill C; Shah B; Politte L; Sanders R; Minjarez M; Cowen J; Mullett J; Page C; Ward D; Deng Y; Loo S; Dziura J; McDougle CJ;
    Am J Psychiatry; 2015 Dec; 172(12):1197-206. PubMed ID: 26315981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-label pilot study of quetiapine treatment for cannabis dependence.
    Mariani JJ; Pavlicova M; Mamczur AK; Bisaga A; Nunes EV; Levin FR
    Am J Drug Alcohol Abuse; 2014 Jul; 40(4):280-4. PubMed ID: 24963729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents.
    Rizzo R; Martino D
    Expert Rev Neurother; 2015 Apr; 15(4):347-54. PubMed ID: 25800130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder.
    Sayer GR; McGough JJ; Levitt J; Cowen J; Sturm A; Castelo E; McCracken JT
    J Child Adolesc Psychopharmacol; 2016 Dec; 26(10):882-888. PubMed ID: 27483130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanfacine extended release as adjunctive therapy to psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Childress AC
    Adv Ther; 2012 May; 29(5):385-400. PubMed ID: 22610723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, controlled, phase III trial.
    Hervas A; Huss M; Johnson M; McNicholas F; van Stralen J; Sreckovic S; Lyne A; Bloomfield R; Sikirica V; Robertson B
    Eur Neuropsychopharmacol; 2014 Dec; 24(12):1861-72. PubMed ID: 25453486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-Release Guanfacine Does Not Show a Large Effect on Tic Severity in Children with Chronic Tic Disorders.
    Murphy TK; Fernandez TV; Coffey BJ; Rahman O; Gavaletz A; Hanks CE; Tillberg CS; Gomez LI; Sukhodolsky DG; Katsovich L; Scahill L
    J Child Adolesc Psychopharmacol; 2017 Nov; 27(9):762-770. PubMed ID: 28723227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Guanfacine Extended-Release Formulation in Healthy Japanese and Caucasian Male Adults.
    Matsuo Y; Okita M; Ermer J; Wajima T
    Clin Drug Investig; 2017 Aug; 37(8):745-753. PubMed ID: 28421383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanfacine ER for the treatment of adolescent attention-deficit/hyperactivity disorder.
    Bukstein OG; Head J
    Expert Opin Pharmacother; 2012 Oct; 13(15):2207-13. PubMed ID: 22957772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two case reports of extended-release guanfacine overdose in children.
    Shimozato A; Ohashi K; Saitoh S
    Pediatr Int; 2023 Jan; 65(1):e15424. PubMed ID: 36412228
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and Safety of Guanfacine Extended-Release in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled Study.
    Iwanami A; Saito K; Fujiwara M; Okutsu D; Ichikawa H
    J Clin Psychiatry; 2020 Apr; 81(3):. PubMed ID: 32297719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An update on the pharmacological treatment of attention deficit hyperactivity disorder: lisdexamphetamine and extended-release guanfacine].
    Martin Fernandez-Mayoralas D; Fernandez-Perrone AL; Munoz-Jareno N; Fernandez-Jaen A
    Rev Neurol; 2017 Mar; 64(s02):S1-S8. PubMed ID: 28272733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Psychopharmacology Trials: Beyond Efficacy.
    Emslie GJ
    Am J Psychiatry; 2015 Dec; 172(12):1171-2. PubMed ID: 26619768
    [No Abstract]   [Full Text] [Related]  

  • 19. A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Wilens TE; Robertson B; Sikirica V; Harper L; Young JL; Bloomfield R; Lyne A; Rynkowski G; Cutler AJ
    J Am Acad Child Adolesc Psychiatry; 2015 Nov; 54(11):916-25.e2. PubMed ID: 26506582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination treatment with guanfacine extended release and blonanserin for Tourette's syndrome comorbid with attention deficit hyperactivity disorder.
    Kawabe K; Horiuchi F; Ueno SI
    Psychiatry Clin Neurosci; 2019 Dec; 73(12):762-763. PubMed ID: 31588606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.